-
Vaccine makers could make Omicron-specific booster, says Fauci
expresspharma
December 07, 2021
The US government is working with Moderna, Pfizer and J&J on multiple contingency plans, infectious disease expert Anthony Fauci told reporters at a White House briefing.
-
COVID-19 Vaccine, Testing Demand Overwhelming Pharmacies
Drugs
December 07, 2021
U.S. pharmacies are struggling to keep up with Americans' demand for COVID-19 vaccines and tests, and the pressure could intensify as antiviral pills to treat COVID-19 are approved by federal regulators.
-
Putin hopes WHO soon approves Russia's Sputnik V vaccine
PharmaTimes
December 06, 2021
Russian President Vladimir Putin said Sunday that he hoped for a quick approval of the country's Sputnik V coronavirus vaccine by the World Health Organization, saying the move is essential for expanding global supplies, as reported by ABC News.
-
Pfizer accused of funding anti-AstraZeneca information
FirstWordPharma
December 06, 2021
Pfizer, co-developer of the Comirnaty coronavirus vaccine, has been accused of funding educational presentations that claim AstraZeneca's rival shot was ineffective and even dangerous for some members of the population, reported CityAM.
-
With Holidays Ahead, COVID Boosters a Must for People With Weak Immune Systems
Drugs
December 06, 2021
If you're a patient with a weakened immune system, roll up your sleeves to stay safe over the holidays and winter months.
-
Odds of SARS-CoV-2 Infection Down After Third BNT162b2 Dose
Drugs
December 06, 2021
Receipt of a third booster BNT162b2 dose is associated with a reduction in the odds of testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to a study published online Nov. 30 in JAMA Internal Medicine.
-
EMA begins rolling review of Valneva’s Covid-19 vaccine candidate VLA2001
Pharmaceutical-Business-Review
December 06, 2021
Valneva stated that it is now focused on securing regulatory approvals for VLA2001 after the positive results from the Phase III trial.
-
EMA initiates rolling review of Valneva’s COVID-19 vaccine (VLA2001)
EuropeanPharmaceuticalReview
December 06, 2021
The European Medicines Agency (EMA)’s human medicines committee (CHMP) has begun a rolling review of VLA2001, a COVID-19 vaccine being developed by Valneva...
-
SCHOTT Continues to Expand U.S. Presence
contractpharma
December 03, 2021
Setting a strategic portfolio in the U.S. aims to capitalize on the world’s largest economy and capacity for innovation.
-
ZyCoV-D to be used in seven states initially
expresspharma
December 03, 2021
The seven states are Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar Pradesh and West Bengal